Similar articles

• Rational use of psychotropic drugs. III. Major tranquilizers.

  Greenblatt DJ, Shader RI. Greenblatt DJ, et al. Am J Hosp Pharm. 1974 Dec;31(12):1226-31. Am J Hosp Pharm. 1974. PMID: 4156455 Review. No abstract available.
• [Comparative study of 2 drugs and a placebo in chronic schizophrenia].

  Tetreault L. Tetreault L. Actual Pharmacol (Paris). 1969;22:1-18. Actual Pharmacol (Paris). 1969. PMID: 4927120 Clinical Trial. French. No abstract available.
• Drug therapy.

  Stone WN, Hofling CK, Winslow WW. Stone WN, et al. Prog Neurol Psychiatry. 1968;23:563-81. Prog Neurol Psychiatry. 1968. PMID: 4890081 Review. No abstract available.
• A PRELIMINARY STUDY OF P-5227, a new active tricyclic antipsychotic agent.

  Simpson GM, Iqbal J, Iqbal F, Angus JW. Simpson GM, et al. Curr Ther Res Clin Exp. 1966 Oct;8(10):465-71. Curr Ther Res Clin Exp. 1966. PMID: 4961022 Clinical Trial. No abstract available.
• [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].

  Degkwitz R, Bauer MP, Gruber M, Hampel G, Luxenburger O, Richartz M, Wenzel W. Degkwitz R, et al. Arzneimittelforschung. 1970 Jul;20(7):890-3. Arzneimittelforschung. 1970. PMID: 4918918 Clinical Trial. German. No abstract available.